RT @DrImranSheikh: Clinical considerations of CDK4/6 inhibitors in HER2 positive breast cancer: Deregulation of cell cycles can result in a…
12,152 followers
18,077 followers
Clinical considerations of CDK4/6 inhibitors in HER2 positive breast cancer: Deregulation of cell cycles can result in a variety of cancers, including breast cancer (BC). In fact, abnormal regulation of cell cycle pathways is…… #oncology https://t.co/btPw
12,152 followers
RT @FrontOncology: New research: Clinical considerations of CDK4/6 inhibitors in HER2 positive breast cancer: Deregulation of cell cycles c…
6,546 followers
New research: Clinical considerations of CDK4/6 inhibitors in HER2 positive breast cancer: Deregulation of cell cycles can result in a variety of cancers, including breast cancer (BC). In fact, abnormal regulation of cell cycle pathways is… https://t.co/lj